Status:
UNKNOWN
Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy
Lead Sponsor:
Safaa AA Khaled
Conditions:
ITP - Immune Thrombocytopenic Purpura
Viral Hepatitis
Eligibility:
All Genders
18-75 years
Brief Summary
Aim of the work To estimate frequency of viral HB \& C infection in ITP patients who received triple therapy in comparison with another group treated with steroids only. To explore risk factors and r...
Detailed Description
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia in the absence of other causes.ITP is mediated by antiplatelet autoantibodies. Antibody-coate...
Eligibility Criteria
Inclusion
- ITP patients received triple therapy or steroids only more than 18 years old
Exclusion
- All ITP patient less than 18 years old or treated with other regimens except triple therapy or steroids.
- Patients with other bleeding disorders ITP patients with known viral hepatitis B \& C infection before triple therapy
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04113915
Start Date
November 1 2019
End Date
December 1 2020
Last Update
November 1 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.